| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0004 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0004 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0005 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0005 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.23 | 0.0008 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0008 |